ClearPoint Neuro, Inc. CLPT shares soared 8.1% in the last trading session to close at $10. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 26.4% loss over the past four weeks.
ClearPoint Neuro scored a strong price increase on investors’ optimism surrounding the company’s impending fourth quarter 2025 financial results, which is slated to release on March 17, 2026. Per the Zacks Consensus Estimate, the company’s revenues are expected to increase 24.8% year over year. Loss per share is pegged at 22 cents for the fourth quarter.
This company is expected to post quarterly loss of $0.22 per share in its upcoming report, which represents a year-over-year change of -10%. Revenues are expected to be $9.7 million, up 24.8% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For ClearPoint Neuro, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CLPT going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
ClearPoint Neuro is part of the Zacks Medical - Instruments industry. EDAP TMS S.A. EDAP, another stock in the same industry, closed the last trading session 2.8% lower at $4.13. EDAP has returned 6.3% in the past month.
EDAP TMS' consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.16. Compared to the company's year-ago EPS, this represents a change of -220%. EDAP TMS currently boasts a Zacks Rank of #4 (Sell).
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>ClearPoint Neuro, Inc. (CLPT) : Free Stock Analysis Report
EDAP TMS S.A. (EDAP) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
